SYMETRYX CORP enters NEUBASE THERAPEUTICS, INC. with 618.92K shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 9/1/2023ACC: 0001991925-23-000001
618.92K
Baseline shares
100% direct
618.92K
Direct ownership
5 positions
0.00
Derivative underlying
0 instruments
5
Security positions
All direct
Non-Derivative Holdings5
Common Stock, Par Value $0.0001 per Share
DirectShares owned36.48K
Common Stock, Par Value $0.0001 per Share
DirectShares owned3.80K
Common Stock, Par Value $0.0001 per Share
DirectShares owned428.44K
Common Stock, Par Value $0.0001 per Share
DirectShares owned44.49K
Common Stock, Par Value $0.0001 per Share
DirectShares owned105.71K
Total
618.92K direct618.92K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, Par Value $0.0001 per Share | 36.48K | Direct |
| Common Stock, Par Value $0.0001 per Share | 3.80K | Direct |
| Common Stock, Par Value $0.0001 per Share | 428.44K | Direct |
| Common Stock, Par Value $0.0001 per Share | 44.49K | Direct |
| Common Stock, Par Value $0.0001 per Share | 105.71K | Direct |
| Total | 618.92K | 618.92K direct |
Derivative Holdings0
No derivative holdings reported